Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranibizumab and Vitrectomy in the Therapy of Diabetic Macular Edema
DRKS00005443Phase 4Terminated
- Sponsor
- Bergman Clinics Augenklinik Universitätsallee
- Start
- Nov 2013
- Modality
- Antibody Fragments → Engineered Antibody Formats → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ranibizumab in diabetic macular edema (DME) (2 arms), sponsored by Bergman Clinics Augenklinik Universitätsallee. Started Nov 2013; status: terminated.
02
Drugs
ranibizumab
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on DRKS00005443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00005443.